Cassava Sciences, Inc.
Recorded under 2 name spellings.
Recorded as renamed to Filana Therapeutics, Inc. (2026)
Previously recorded as Pain Therapeutics, Inc. (to 2023)
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,760,052 | Method of inhibiting tau phosphorylation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,222,368 | Alzheimer's disease assay in a living patient In force · From the USPTO record | In force | From the USPTO record | |
| US 10,017,736 | Method of inhibiting tau phosphorylation In force · From the USPTO record | In force | From the USPTO record | |
| US 9,500,640 | Alzheimer's disease assay in a living patient In force · From the USPTO record | In force | From the USPTO record | |
| US 11,096,936 | Cocrystals of naloxone and naltrexone In force · From the USPTO record | In force | From the USPTO record | |
| US 11,370,791 | Solid Polymorphs of a Flna-Binding Compound and Its Hydrochloride Salts In force · High confidence | In force | High confidence | |
| US 12,065,440 | Solid Polymorphs of a Flna-Binding Compound and Its Hydrochloride Salts In force · Medium confidence | In force | Medium confidence | |
| US 12,391,693 | Solid Polymorphs of a Flna-Binding Compound and Its Hydrochloride Salts In force · Medium confidence | In force | Medium confidence |
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned · 1 no status recorded
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/802,950 | Solid Polymorphs of a Flna-Binding Compound and Its Hydrochloride Salts | Aug 13, 2024 | Pending |
| 18/323,075 | May 24, 2023 | No status recorded | |
| 18/291,014 | Component Assay for Alzheimer's Disease in a Living Subject | Jul 22, 2022 | Pending |
| 17/814,486 | Jul 22, 2022 | Abandoned | |
| 17/517,879 | Inhibiting an Immune Response Mediated by One or More of TLR2, Rage, CCR5, CXCR4 and CD4 | Nov 3, 2021 | Pending |